Industrial and Commercial Bank of China, the nation’s biggest lender by assets, rose to a nine-year high in Shanghai, as traders snapped up the cheap index-weighting stock to drive up the equity benchmark past a key resistance level. Shares of ICBC ... ( read original story ...)
BRIEF-Bank of Shanghai’s H1 net profit up 6.6 pct y/y
Further company coverage: ($1 = 6.6529 Chinese yuan renminbi) (Reporting by Hong Kong newsroom) Our Standards:The Thomson Reuters Trust Principles. ( read original story ...)
China stocks end lower, weighed by losses in commodities producers
Trading volumes on the Shanghai exchange were 15 per cent below the 30-day average. The CSI 300 Index of large companies recovered earlier losses and edged up 0.1 per cent, or 3.8 points, to 3,756. Hong Kong cancelled the day’s stock and futures trading ... ( read original story ...)
Shanghai Fosun Pharmaceutical Group Co Ltd 600196 Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of.. ( read original story ...)
Shanghai Jiao Da Onlly Co Ltd 600530 Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a.. ( read original story ...)
China’s yuan rises after c.bank fixes midpoint at 11-month high
SHANGHAI, Aug 22 (Reuters) - China's yuan firmed against the U.S. dollar on Tuesday after the central bank set the midpoint at its firmest in 11 months, as the Chinese currency continued to benefit from a soft dollar. Prior to market opening, the People's ... ( read original story ...)
China’s IPO bonanza loses lustre as returns dwindle
“Decreasing returns from IPO shares will become a norm in the future, with increased supply and regulatory scrutiny,” said Wu Kan, a fund manager at Shanshan Finance in Shanghai. “Exceptionally generous returns were previously built on not-too-fast suppl ( read original story ...)